Multi Radiance Medical Announces a Ground-Breaking Achievement in Translational Research
For Immediate Release:
August 19, 2014 – SOLON, Ohio--(BUSINESS WIRE)--Multi Radiance Medical (MRM), manufacturer and marketer of FDA-cleared lasers for drug-free pain relief, announces that its Clinical Research Trial for treating Knee Pain is among the first translational research studies performed with Photobiomodulation.
“This study is ground-breaking in the sense that it moves the research in Photobiomodulation from statistically significant to clinically significant,” states Max Kanarsky, President and CEO of Multi Radiance. “This is the new gold standard in research, a level even above evidence based research.”
The study was conducted with the MRM MR4 Super Pulsed Laser in a randomized, double-blind, placebo-controlled environment with the following conclusions:
- Photobiomodulation significantly decreased pain and significantly improved SF-36® physical component summary at post-treatments and follow-up assessments compared to placebo.
- Outcomes were maintained at the 30-day follow up.
- A combination of super pulsed laser, red and infrared LEDs is effective for decreasing pain and improving the quality of life in patients with knee pain.
The Study included 86 patients being treated for all types of knee pain with a standard methodology call the Priority Principle™. The methodology was developed by Douglas S. Johnson, ATC, EES, CLS who was closely involved with the project.
“The article was accepted for publication by Lasers in Medical Science and is now available as an e-publication ahead of print,” Johnson said. “We will also be presenting the findings at the upcoming joint meeting of the World Association of Laser Therapy and the North American Association of Laser and Light Therapy held this September in Washington, DC.”
Dr. Ernesto Leal Junior, PhD, PT, the lead researcher on the study and a prominent researcher in the field of Photobiomodulation, states, “This study represents a shift in research since we focused on patient-based outcomes. Currently, research in the Photobiomodulation field has generated outcomes that generally are difficult to translate into clinical practice, which creates a gap. Undoubtedly, this study fills the gap and represents real translational research.”
About Multi Radiance Medical
Multi Radiance Medical is a global leader in the development and manufacturing of FDA-cleared lasers for drug-free pain relief. This proprietary technology is considered the safest laser on the market and is utilized to treat over 300 conditions worldwide.